Rapport Therapeutics (RAPP)

Profile

Full Name

Rapport Therapeutics, Inc.

Ticker Symbol

RAPP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.rapportrx.com

Employees

69

Key Details

Price

$8.63(-3.90%)

Market cap

$314.96M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.78(+83.64% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.63
RAPP price is $8.63

30-Day Relative Volume

0.35
RAPP 30-day relative volume is 0.35

Price Performance

Price Most recent change

-3.9%
RAPP price was down -3.9% on Apr 10, 2025

Price YTD change

-51.35%
RAPP price is down -51.35% since January 1st

Price 1-year change

-
RAPP price 1-year change is unknown

Price 3-year change

-
RAPP price 3-year change is unknown

Price Range

Price All-time high

$29.74
RAPP price is currently -70.98% below its historical high of $29.74

Price 3-year low

$6.43
RAPP price is currently +34.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$314.96M
RAPP market capitalization is $314.96 million

Market cap 3-year change

-
RAPP market capitalization 3-year change is unknown

Market cap All-time high

$1.07B
RAPP market capitalization is currently -70.54% below its historical high of $1.07 billion

Market cap sector rank

64.59%
RAPP market capitalization is higher than 64.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.17%
RAPP shares outstanding is up +3.17% year-on-year

Shares Outstanding 3-Year Change

-
RAPP shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.23
RAPP beta is 1.23

200-day SMA

$18.69
RAPP price is currently -53.82% below its 200-day simple moving average

50-day SMA

$11.65
RAPP price is currently -25.92% below its 50-day simple moving average

RSI

40.46
RAPP 14-day relative strength index is 40.46

Volume

0.35
RAPP 30-day relative volume is 0.35

ATR

$1.25
RAPP average true range is $1.25

10-day Historical Volatility

107.10%
RAPP 10-day historical volatility is 107.10%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
RAPP annual revenue value is unknown

Revenue Analysts estimate

-
RAPP annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
RAPP annual revenue 1-year change is unknown

Revenue Sector rank

-
RAPP annual revenue is unknown

EPS

EPS

-$3.78
RAPP annual earnings per share is -$3.78

EPS Analysts estimate

-$3.63
RAPP annual earnings per share is currently +4.13% higher than the consensus analysts' forecast

EPS 1-year change

+83.64%
RAPP annual earnings per share is up +83.64% year-on-year

EPS Sector rank

23.7%
RAPP annual earnings per share is higher than 23.7% of companies in Healthcare sector

Profit

Gross profit

-
RAPP annual gross profit value is unknown

Gross margin

-
RAPP annual gross profit margin value is unknown

Operating profit

-$83.06M
RAPP annual operating income is -$83.06 million

Operating margin

-
RAPP annual operating profit margin value is unknown

Net income

-$78.31M
RAPP annual net profit is -$78.31 million

Net margin

-
RAPP annual net profit margin value is unknown

Expenses

Total expenses

$83.06M
RAPP annual total expenses is $83.06 million

Operating expenses

$83.06M
RAPP annual total operating expenses is $83.06 million

Cost of goods sold

-
RAPP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$22.12M
RAPP annual SGA is $22.12 million

Depreciation and amortization

$839.00K
RAPP annual depreciation & amortization is $839.00 thousand

Interest expense

-
RAPP annual interest expense value is unknown

Income tax

$0.00
RAPP annual income tax is $0.00

EBIT & EBITDA

EBIT

-$83.06M
RAPP annual earnings before interest & taxes is -$83.06 million

EBITDA

-$82.22M
RAPP annual EBITDA is -$82.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$314.93M
RAPP annual total assets is $314.93 million

Non current assets

$5.13M
RAPP annual long term assets is $5.13 million

Current assets

$309.80M
RAPP annual total current assets is $309.80 million

Cash and cash equivalents

$56.80M
RAPP annual cash & cash equivalents is $56.80 million

Accounts receivable

-
RAPP annual accounts receivable value is unknown

Inventory

-
RAPP annual inventory value is unknown

Liabilities

Total liabilities

$9.51M
RAPP annual total liabilities is $9.51 million

Long term liabilities

$739.00K
RAPP annual total long term liabilities is $739.00 thousand

Current liabilities

$8.77M
RAPP annual total current liabilities is $8.77 million

Accounts payable

$1.95M
RAPP annual accounts payable is $1.95 million

Debt

Total debt

$1.48M
RAPP annual total debt is $1.48 million

Total debt 1-year change

-31.22%
RAPP annual total debt is down -31.22% year-on-year

Long term debt

$739.00K
RAPP annual long term debt is $739.00 thousand

Short term debt

$737.00K
RAPP annual short term debt is $737.00 thousand

Equity & Capital

Shareholders equity

$305.43M
RAPP annual stockholders equity is $305.43 million

Book value

$305.43M
RAPP annual book value is $305.43 million

Retained earnings

-$123.75M
RAPP annual retained earnings is -$123.75 million

Working capital

$301.04M
RAPP annual working capital is $301.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$64.83M
RAPP annual cash flow from operations is -$64.83 million

Cash from operations 1-year change

-138.5%
RAPP annual cash flow from operations is down -138.5% year-on-year

Cash from investing

-$170.14M
RAPP annual cash flow from investing activities is -$170.14 million

Cash from investing 1-year change

-115.75%
RAPP annual cash flow from investing activities is down -115.75% year-on-year

Cash from financing

$221.63M
RAPP annual cash flow from financing activities is $221.63 million

Cash from financing 1-year change

+52.7%
RAPP annual cash flow from financing activities is up +52.7% year-on-year

CAPEX

CAPEX

-
RAPP annual capital expenditures value is unknown

CAPEX 1-year change

-
RAPP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$67.23M
RAPP annual free cash flow is -$67.23 million

Free cash flow 1-year change

-133.31%
RAPP annual free cash flow is down -133.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RAPP annual gross profit margin value is unknown

Operating margin

-
RAPP annual operating profit margin value is unknown

Net margin

-
RAPP annual net profit margin value is unknown

ROA & ROE

ROA

-24.86%
RAPP annual return on assets is -24.86%

ROE

-25.64%
RAPP annual return on equity is -25.64%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RAPP price to earnings ratio value is unknown

PE ratio Sector rank

-
RAPP price to earnings ratio is unknown

PB Ratio

PB ratio

1.03
RAPP price to book ratio is 1.03

PB ratio Sector rank

45.81%
RAPP price to book ratio is higher than 45.81% of companies in Healthcare sector

PS Ratio

PS ratio

-
RAPP price to sales ratio value is unknown

PS ratio Sector rank

-
RAPP price to sales ratio is unknown

Enterprise value

Enterprise value

$259.63M
RAPP enterprise value is $259.63 million

Enterprise value Sector rank

62.74%
RAPP enterprise value is higher than 62.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.16
RAPP EV/EBITDA is -3.16

EV/EBITDA Sector rank

23.7%
RAPP EV/EBITDA is higher than 23.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

35.34
RAPP annual current ratio is 35.34

Quick ratio

-
RAPP annual quick ratio value is unknown

Leverage

Debt to equity

0.00
RAPP annual debt to equity ratio is 0.00

Interest coverage ratio

-
RAPP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RAPP piotroski f-score value is unknown

Altman Z-Score

-
RAPP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 8, 25 JMP Securities
Market Outperform
Oct 18, 24 Jones Trading
Buy
Jul 2, 24 TD Cowen
Buy
Jul 2, 24 Stifel
Buy
Jul 2, 24 Jefferies
Buy

Institutional Ownership

Similar stocks

SMLR logo
Semler Scientific (SMLR)
TCMD logo
Tactile Systems Technology (TCMD)
ABSI logo
Absci (ABSI)
MPLN logo
MultiPlan (MPLN)
Claritev (CTEV)
Tectonic Therapeutic (TECX)
VREX logo
Varex Imaging (VREX)
TRML logo
Tourmaline Bio (TRML)
ALT logo
Altimmune (ALT)
  • What is the ticker symbol for Rapport Therapeutics?
  • Does Rapport Therapeutics pay dividends?
  • What sector is Rapport Therapeutics in?
  • What industry is Rapport Therapeutics in?
  • What country is Rapport Therapeutics based in?
  • Is Rapport Therapeutics in the S&P 500?
  • Is Rapport Therapeutics in the NASDAQ 100?
  • Is Rapport Therapeutics in the Dow Jones?
  • When was Rapport Therapeutics's last earnings report?
  • When does Rapport Therapeutics report earnings?
  • Should I buy Rapport Therapeutics stock now?

What is the ticker symbol for Rapport Therapeutics?

The ticker symbol for Rapport Therapeutics is NASDAQ:RAPP

Does Rapport Therapeutics pay dividends?

No, Rapport Therapeutics does not pay dividends

What sector is Rapport Therapeutics in?

Rapport Therapeutics is in the Healthcare sector

What industry is Rapport Therapeutics in?

Rapport Therapeutics is in the Biotechnology industry

What country is Rapport Therapeutics based in?

Rapport Therapeutics is headquartered in United States

Is Rapport Therapeutics in the S&P 500?

No, Rapport Therapeutics is not included in the S&P 500 index

Is Rapport Therapeutics in the NASDAQ 100?

No, Rapport Therapeutics is not included in the NASDAQ 100 index

Is Rapport Therapeutics in the Dow Jones?

No, Rapport Therapeutics is not included in the Dow Jones index

When was Rapport Therapeutics's last earnings report?

Rapport Therapeutics's most recent earnings report was on Mar 11, 2025

When does Rapport Therapeutics report earnings?

The next expected earnings date for Rapport Therapeutics is May 30, 2025

Should I buy Rapport Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page